Targeted Approaches in Metastatic Castration-Resistant Prostate Cancer: Which Data?

SIMPLE SUMMARY: Castration-resistant prostate cancer (CRPC) remains an incurable disease, but some promising innovative treatment options are under investigation. Recent developments in precision medicine have enabled the identification of new predictive biomarkers and potential targeted agents. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosillo, Claudia, Calandrella, Maria Letizia, Caserta, Claudia, Macrini, Serena, Guida, Annalisa, Sirgiovanni, Grazia, Bracarda, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454420/
https://www.ncbi.nlm.nih.gov/pubmed/36077726
http://dx.doi.org/10.3390/cancers14174189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454420/
https://www.ncbi.nlm.nih.gov/pubmed/36077726
http://dx.doi.org/10.3390/cancers14174189

Ejemplares similares